The effect of topical tacrolimus on severe recalcitrant chronic discoid lupus erythematosus [14]

British Journal of Dermatology

Volumn 147, Issue 2, 2002, Pages 405-

  Walker, S L ^a   Kirby, B ^a   Chalmers, R J G ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CLOBETASOL PROPIONATE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROXYCHLOROQUINE; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; MEPACRINE; PREDNISOLONE; TACROLIMUS; THALIDOMIDE; TUMOR NECROSIS FACTOR;

ADULT; CASE REPORT; CLINICAL FEATURE; DISCOID LUPUS ERYTHEMATOSUS; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; FEMALE; GENE ACTIVATION; HUMAN; LETTER; NERVE CONDUCTION; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0036379454     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2002.488616.x     Document Type: Letter

References (6)

1. Rowell NR, Goodfield MJD. The connective tissue diseases. In: Textbook of Dermatology (Champion RH, Burton JL, Burns DA, Breathnach SM, eds), 6th edn, Vol. 3. Oxford: Blackwell Science, 1998; 2437-575.
2. Lyon CC, Smith AJ, Beck MH et al. Parastomal pyoderma gangrenosum: clinical features and management. J Am Acad Dermatol 2000; 42: 992-1002.
3. Nasr IS. Topical tacrolimus in dermatology. Clin Exp Dermatol 2000; 25: 250-4.
4. Furukawa F, Imamura S, Takigawa M. FK506: therapeutic effects on lupus dermatoses in autoimmune-prone MRL/Mp-lpr/lpr mice. Arch Dermatol Res 1995; 287: 558-63.
5. Duddridge M, Powell RJ. Treatment of severe and difficult cases of systemic lupus erythematosus with tacrolimus. A report of three cases. Ann Rheum Dis 1997; 56: 690-2.
6. Paller A, Eichenfield LF, Leung DYM et al. A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients. J Am Acad Dermatol 2001; 33: S47-57.